Cargando…

Predictive Biomarkers of Treatment Response in Major Depressive Disorder

Major depressive disorder (MDD) is a highly prevalent, debilitating disorder with a high rate of treatment resistance. One strategy to improve treatment outcomes is to identify patient-specific, pre-intervention factors that can predict treatment success. Neurophysiological measures such as electroe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stolz, Louise A., Kohn, Jordan N., Smith, Sydney E., Benster, Lindsay L., Appelbaum, Lawrence G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669981/ https://www.ncbi.nlm.nih.gov/pubmed/38002530 http://dx.doi.org/10.3390/brainsci13111570

Ejemplares similares

Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2020)

Gene expression biomarkers of response to citalopram treatment in major depressive disorder
por: Mamdani, F, et al.
Publicado: (2011)

Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies
por: Thase, Michael E.
Publicado: (2014)

Suicidal Ideation and Obsessive-Compulsive Disorder: Links and Knowledge
por: Benster, Lindsay L, et al.
Publicado: (2022)

Intrinsic connectomes are a predictive biomarker of remission in major depressive disorder
por: Korgaonkar, Mayuresh S., et al.
Publicado: (2019)

Heart Rate Variability for the Prediction of Treatment Response in Major Depressive Disorder
por: Choi, Kwan Woo, et al.
Publicado: (2020)

6-Sulfatoxymelatonin predicts treatment response to fluoxetine in major depressive disorder
por: Jury Freitas, Juliana, et al.
Publicado: (2019)

Neuroimaging-based biomarkers for treatment selection in major depressive disorder
por: Dunlop, Boadie W., et al.
Publicado: (2014)

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder
por: Leuchter, Andrew F., et al.
Publicado: (2014)

Personalized relapse prediction in patients with major depressive disorder using digital biomarkers
por: Vairavan, Srinivasan, et al.
Publicado: (2023)

Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder
por: Fan, Siyan, et al.
Publicado: (2020)

The association of COMT genotype with buproprion treatment response in the treatment of major depressive disorder
por: Fawver, Jay, et al.
Publicado: (2020)

Identifying circulating biomarkers for major depressive disorder
por: Zhang, En, et al.
Publicado: (2023)

ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
por: Chang, Buru, et al.
Publicado: (2019)

Dynamic Functional Connectivity Predicts Treatment Response to Electroconvulsive Therapy in Major Depressive Disorder
por: Dini, Hossein, et al.
Publicado: (2021)

Synaptic plasticity and mental health: methods, challenges and opportunities
por: Appelbaum, Lawrence G., et al.
Publicado: (2022)

Neurobehavioral measures of coincidence anticipation timing
por: Stolz, Louise A., et al.
Publicado: (2023)

Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder
por: Martens, Marieke A. G., et al.
Publicado: (2021)

Epigenetic prediction of major depressive disorder
por: Barbu, Miruna C., et al.
Publicado: (2020)

Peripheral Biomarkers in Animal Models of Major Depressive Disorder
por: Carboni, Lucia
Publicado: (2013)

Biomarkers of Major Depressive Disorder: Knowing is Half the Battle
por: Malik, Sahil, et al.
Publicado: (2021)

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

Uncovering the Roles of MicroRNAs in Major Depressive Disorder: From Candidate Diagnostic Biomarkers to Treatment Response Indicators
por: Homorogan, Claudia, et al.
Publicado: (2021)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

Comparison of Peripheral Biomarkers and Reduction of Stress Response in Patients With Major Depressive Disorders vs. Panic Disorder
por: Park, Mi Jin, et al.
Publicado: (2022)

Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder
por: McCarthy, Brian, et al.
Publicado: (2023)

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Desvenlafaxine in the treatment of major depressive disorder
por: Lourenco, Maria Teresa C, et al.
Publicado: (2009)

Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
por: Young, Juan Joseph, et al.
Publicado: (2016)

Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder
por: Horne, Rachael, et al.
Publicado: (2018)

C-Reactive Protein as a Biomarker for Major Depressive Disorder?
por: Orsolini, Laura, et al.
Publicado: (2022)

Peripheral Blood Circular RNAs as a Biomarker for Major Depressive Disorder and Prediction of Possible Pathways
por: Zhang, Dandan, et al.
Publicado: (2022)

Treatment Response Prediction for Major Depressive Disorder Patients via Multivariate Pattern Analysis of Thalamic Features
por: Li, Hanxiaoran, et al.
Publicado: (2022)

Predicting treatment response using EEG in major depressive disorder: A machine-learning meta-analysis
por: Watts, Devon, et al.
Publicado: (2022)

Repetitive transcranial magnetic stimulation treatment of major depressive disorder and comorbid chronic pain: response rates and neurophysiologic biomarkers
por: Corlier, Juliana, et al.
Publicado: (2023)

Electrophysiological biomarkers and age characterize phenotypic heterogeneity among individuals with major depressive disorder
por: Key, Alexandra P., et al.
Publicado: (2023)

Inflammation as a Predictive Biomarker for Response to Omega-3 Fatty Acids in Major Depressive Disorder: A Proof of Concept Study
por: Rapaport, Mark Hyman, et al.
Publicado: (2015)

PS46. Distinct and shared morphometric biomarkers of depressed individuals with bipolar disorder and major depressive disorder
por: Matsuo, Koji, et al.
Publicado: (2016)

Magnetic resonance imaging for individual prediction of treatment response in major depressive disorder: a systematic review and meta-analysis
por: Cohen, Sem E., et al.
Publicado: (2021)

A wavelet-based technique to predict treatment outcome for Major Depressive Disorder
por: Mumtaz, Wajid, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b0vq3ou9neop1vsqulqtlqlpfm